1 Citaat (Scopus)
228 Downloads (Pure)

Samenvatting

Current available maintenance pharmacotherapy for bipolar disorder (BD) leaves ample room for improvement. Up to 50% of patients with BD do not respond adequately to available treatments and still suffer from manic and/or depressive episodes. In this perspective article, we will give an overview of the neuropharmacodynamics of (low-dose) aspirin, reflect on the published clinical studies and argue that aspirin is a promising, yet understudied option for recurrence prevention This article is protected by copyright. All rights reserved.

Originele taal-2English
Pagina's (van-tot)13-15
Aantal pagina's3
TijdschriftBipolar Disorders
Volume21
Nummer van het tijdschrift1
Vroegere onlinedatum25-nov-2018
DOI's
StatusPublished - feb-2019

Citeer dit